• Skip to main content

DistilNFO Health

Health Sector News from India

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

ASCI Welcomes Health Ministry’s Move to Update Healthcare Ad Regulations

Share:

February 12, 2020

Quacks, fake doctors and illegal mobile dispensaries had better watch out. The Indian ministry of health & family welfare (MHFW) is taking steps to take you out of business.

Under the draft Drugs and Magic Remedies (Objectionable Advertisements) (DMR) (Amendment) Bill, 2020, it is seeking to levy fines of Rs 5 lakh and  imprisonment of two years on violators for the first offence, going up to as much as five years in gaol and a fine of Rs 50 lakh for subsequent violations. The various disorders and illnesses have also been clearly defined, while what constitutes an ad in modern times has also been spelt out. The MHFW is seeking the public’s feedback on the DMR Amendment Bill 2020.

The effort by the ministry to update the older act has met with the approval of the advertising industry’s watchman the Advertising Standards Council of India (Asci). Its secretary Shweta Purandare got into a tele-conversation with indiantelevision.com and said that the amendment will help it police the healthcare sector better. “The proposed DMR bill 2020 is an important development and would lend strong support to ASCI’s efforts of suo motu monitoring of misleading advertisements in the healthcare sector,” she said. “Consequences of advertisements in violation of DMR regulations are serious and this would result in better compliance from advertisers as well as media concerned, be it an advertisement of allopathic products or Ayush products.”

The draft bill has listed the diseases and conditions which will come under its umbrella. These include: AIDS, blindness, blood poisoning, bronchial asthma, cancer benign tumour, cataract, change in colour of hair and growth of new hair, change of foetal sex by drugs, congenital malformations, deafness, diabetes, diseases and disorders of the uterus, obesity, fairness of the skin, form and structure of the breast, genetic disorders, improvement in size and shape of the sexual organ and in duration of sexual performance, improvement in height of children or adults, mental retardation, sub normalities, and growth.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Purandare further stated, “Apart from print and TV, it will be interesting to see the impact of advertisements on social media as well as on the advertisers’ websites. We would expect this effect to trickle to advertisements by Ayush doctors and clinics propagating ‘guaranteed cure’ as the Central Council of Indian Medicine has taken cognizance of DMR violations in the past and had issued an advisory to state councils for their action.”

Source: Indian Television

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

Related Posts

  • National Digital Health Mission Rolled Out on Pilot Mode in 6 Union TerritoriesNational Digital Health Mission Rolled Out on Pilot Mode in 6 Union Territories
  • Public Health Policies Must be Kept Out of Indo-U.S. Trade Talks, say Doctors, Patients GroupsPublic Health Policies Must be Kept Out of Indo-U.S. Trade Talks, say Doctors, Patients Groups
  • Telemedicine: the Next Technology Frontier in the Healthcare Ecosystem in IndiaTelemedicine: the Next Technology Frontier in the Healthcare Ecosystem in India
  • Explained: What is the National Health ID Announced by PM Modi?Explained: What is the National Health ID Announced by PM Modi?
  • Reducing the Risk to Children’s Health in Flood-prone Areas of IndiaReducing the Risk to Children’s Health in Flood-prone Areas of India
  • How Sigma Healthcare Elevated B2B Customer ExperienceHow Sigma Healthcare Elevated B2B Customer Experience
  • ‘Focus on the Patient and the Rest Will Follow’‘Focus on the Patient and the Rest Will Follow’
  • Diagnostic Testing Kit for Covid-19 Approved By ICMRDiagnostic Testing Kit for Covid-19 Approved By ICMR

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications